(Q51703765)

10 April 2018

meta-analysis

0 references

title

The prognostic value and clinicopathological significance of CD44 expression in ovarian cancer: a meta-analysis. (English)

1 reference

10 April 2018

1 reference

Luyang Zhao

1

1 reference

10 April 2018

Chenglei Gu

2

1 reference

10 April 2018

Ke Huang

3

1 reference

10 April 2018

Zhe Zhang

4

1 reference

10 April 2018

Mingxia Ye

5

1 reference

10 April 2018

Wensheng Fan

6

1 reference

10 April 2018

Weidong Han

7

1 reference

10 April 2018

Yuanguang Meng

8

1 reference

10 April 2018

publication date

14 June 2016

1 reference

10 April 2018

Archives of Gynecology and Obstetrics

published in

1 reference

10 April 2018

volume

294

1 reference

10 April 2018

issue

5

1 reference

10 April 2018

page(s)

1019-1029

1 reference

10 April 2018

https://scigraph.springernature.com/pub.10.1007/s00404-016-4137-3

exact match

0 references

cites work

Cancer statistics, 2016

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

The cancer stem cell hypothesis: failures and pitfalls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

CD44: structure, function, and association with the malignant process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Direct binding of hepatocyte growth factor and vascular endothelial growth factor to CD44v6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

A self-enforcing CD44s/ZEB1 feedback loop maintains EMT and stemness properties in cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Meta-Analysis of Prognostic and Clinical Significance of CD44v6 in Esophageal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

CD44 expression in curettage and postoperative specimens of endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Practical methods for incorporating summary time-to-event data into meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

The CD44 Receptor Is a Molecular Predictor of Survival in Ovarian Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Prevalence of epithelial ovarian cancer stem cells correlates with recurrence in early-stage ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Expression of CD44v6 and Its Association with Prognosis in Epithelial Ovarian Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

High expression of Lewis y antigen and CD44 is correlated with resistance to chemotherapy in epithelial ovarian cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Correlation of CD44v6 expression with ovarian cancer progression and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

CD44 standard form expression is correlated with high-grade and advanced-stage ovarian carcinoma but not prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Expression and significance of CD44, CD47 and c-met in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Predictive markers of chemoresistance in advanced stages epithelial ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Mechanism and biological significance of CD44 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Hyaluronan: from extracellular glue to pericellular cue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Hyaluronan binding properties of a CD44 chimera containing the link module of TSG-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Organizing the cell cortex: the role of ERM proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Soluble CD44 concentration in the serum and peritoneal fluid samples of patients with different stages of endometriosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Enrichment of CD44 in basal-type breast cancer correlates with EMT, cancer stem cell gene profile, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Prognostic role of CD44 expression in osteosarcoma: evidence from six studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

Targeting the mechanisms of resistance to chemotherapy and radiotherapy with the cancer stem cell hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00404-016-4137-3

10.1007/S00404-016-4137-3

21 January 2018

Identifiers

DOI

1 reference

10 April 2018

1 reference

10 April 2018